These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16896073)

  • 1. Vaccine trials guide pandemic plans.
    Traynor K
    Am J Health Syst Pharm; 2006 Aug; 63(16):1482-3. PubMed ID: 16896073
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines for a potential influenza pandemic.
    Auewarakul P; Thongcharoen P
    Future Microbiol; 2007 Jun; 2(3):345-9. PubMed ID: 17661708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza pandemic vaccines: how to ensure a low-cost, low-dose option.
    Stöhr K; Kieny MP; Wood D
    Nat Rev Microbiol; 2006 Aug; 4(8):565-6. PubMed ID: 16888876
    [No Abstract]   [Full Text] [Related]  

  • 4. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS
    Biologicals; 2008 Nov; 36(6):346-9. PubMed ID: 18715803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pandemic threat: are we prepared?
    Lewis KK
    Issue Brief (Mass Health Policy Forum); 2006 Jun; (29):1-14. PubMed ID: 16886304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007.
    Wkly Epidemiol Rec; 2007 May; 82(19):164-7. PubMed ID: 17500103
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaccine preparedness--are we ready for the next influenza pandemic?
    Wright PF
    N Engl J Med; 2008 Jun; 358(24):2540-3. PubMed ID: 18550873
    [No Abstract]   [Full Text] [Related]  

  • 9. Live attenuated vaccines for pandemic influenza.
    Chen GL; Subbarao K
    Curr Top Microbiol Immunol; 2009; 333():109-32. PubMed ID: 19768402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Registration of the first human vaccine against the highly pathogenic avian influenza A(H5N1) virus: considerations].
    de Jong JC; Osterhaus AD
    Ned Tijdschr Geneeskd; 2008 Sep; 152(39):2113-5. PubMed ID: 18856026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
    Hasegawa H; Ichinohe T; Tamura S; Kurata T
    Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) [Prepandrix]: a review of its use as an active immunization against influenza A subtype H5N1 virus.
    Carter NJ; Plosker GL
    BioDrugs; 2008; 22(5):279-92. PubMed ID: 18778110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):328-30. PubMed ID: 16933379
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvants for pandemic influenza vaccines.
    Atmar RL; Keitel WA
    Curr Top Microbiol Immunol; 2009; 333():323-44. PubMed ID: 19768413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans.
    Jennings LC; Monto AS; Chan PK; Szucs TD; Nicholson KG
    Lancet Infect Dis; 2008 Oct; 8(10):650-8. PubMed ID: 18922487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal influenza vaccination may mitigate the potential impact of an H5N1 pandemic.
    Qin CF; Qin ED
    Chin Med J (Engl); 2008 Aug; 121(15):1481-3. PubMed ID: 18959131
    [No Abstract]   [Full Text] [Related]  

  • 17. Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.
    Girard M; Palkonyay L; Kieny MP
    Vaccine; 2008 Sep; 26(39):4975-7. PubMed ID: 18514979
    [No Abstract]   [Full Text] [Related]  

  • 18. Which factors are important in adults' uptake of a (pre)pandemic influenza vaccine?
    Zijtregtop EA; Wilschut J; Koelma N; Van Delden JJ; Stolk RP; Van Steenbergen J; Broer J; Wolters B; Postma MJ; Hak E
    Vaccine; 2009 Dec; 28(1):207-27. PubMed ID: 19800997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breaking the immunogenicity barrier of bird flu vaccines.
    Sambhara S; Poland GA
    Lancet; 2007 Aug; 370(9587):544-5. PubMed ID: 17707733
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment and update on influenza prevention and treatment.
    Fiore AE; Shay DK
    Clin Infect Dis; 2007 Sep; 45(5):670-1. PubMed ID: 17683014
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.